Overall, the ability of SIV Nef to modulate T cell activation by downregulating CD3 and CD28 is consistent with a non-pathogenic phenotype, while retaining these receptors on the T cell surface leads to increased T cell activation and inflammation, consistent with a pathogenic infection. The gene discussed is S100B; the disease is infection.